Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Borel Fields's Profile
Displaying 201-250 of 343 result(s).
CYDY CytoDyn Inc
01/06/2021 11:29:50 PM
At the 50% interim, a 50% reduction (3)
CYDY CytoDyn Inc
01/06/2021 11:12:25 PM
Sure, I'll toss in my wild-ass gues (9)
CYDY CytoDyn Inc
01/06/2021 2:06:13 AM
Thanks so much. Another ten or twel (2)
CYDY CytoDyn Inc
01/05/2021 8:15:55 PM
Thanks, CTMedic, I missed that unti (6)
CYDY CytoDyn Inc
01/05/2021 6:03:09 PM
"Thinning, Leaky Brain Blood Vessel (1)
CYDY CytoDyn Inc
01/04/2021 3:50:06 PM
Does that sound like sequencing? GM (1)
CYDY CytoDyn Inc
01/04/2021 3:34:54 PM
You are correct that I was taking t
CYDY CytoDyn Inc
01/04/2021 2:20:06 PM
Help, please, re: leron/lenzi compa (1)
CYDY CytoDyn Inc
01/04/2021 10:50:30 AM
Leronlimab's supply from Samsung is (2)
CYDY CytoDyn Inc
01/04/2021 10:08:33 AM
Not a doc, but both now exclude the (2)
CYDY CytoDyn Inc
01/03/2021 6:26:45 PM
Rub - Given the number of platforms (2)
CYDY CytoDyn Inc
01/02/2021 9:27:14 PM
Anyone know details of NEWS2? I'm w (2)
CYDY CytoDyn Inc
01/02/2021 8:19:45 PM
Good arguments against using all-ca (3)
CYDY CytoDyn Inc
01/02/2021 1:28:54 AM
Another case saying EUAs take time: (3)
CYDY CytoDyn Inc
01/01/2021 2:44:57 AM
The good side of all cause mortalit (5)
CYDY CytoDyn Inc
12/29/2020 7:21:16 PM
Is the 1/21 effective date a typo o
CYDY CytoDyn Inc
12/26/2020 12:47:17 PM
CD-12 survivors are an ongoing long
CYDY CytoDyn Inc
12/26/2020 1:48:20 AM
Certainly, the FDA can see the deat
CYDY CytoDyn Inc
12/22/2020 1:58:49 AM
I worked for a while in a quantitat (3)
CYDY CytoDyn Inc
12/20/2020 2:11:56 AM
Clickbait is enough to track humans (2)
CYDY CytoDyn Inc
12/16/2020 2:23:57 PM
Samsung Mab capacity expanding - gr (6)
CYDY CytoDyn Inc
12/15/2020 11:30:36 AM
Use all the data: P(survive to 42) (6)
CYDY CytoDyn Inc
12/13/2020 7:08:24 PM
What happens at trial sites the day (1)
CYDY CytoDyn Inc
12/12/2020 10:34:46 PM
Was the "expanded access" tab on th (1)
CYDY CytoDyn Inc
12/12/2020 3:31:27 PM
Perfect. Thanks so much - I get the (1)
CYDY CytoDyn Inc
12/12/2020 11:09:49 AM
Thanks, Tech Guru, I used to think
CYDY CytoDyn Inc
12/10/2020 11:56:32 PM
If that's what they did, it is wron
CYDY CytoDyn Inc
11/25/2020 12:16:50 AM
No. I'm talking about post 66504
CYDY CytoDyn Inc
11/24/2020 11:03:32 PM
Exactly. The big thing is being cle
CYDY CytoDyn Inc
11/24/2020 5:33:38 PM
Simple product P(survive 42) = (# s (1)
CYDY CytoDyn Inc
11/24/2020 4:58:26 PM
The Cox model is the generalization (2)
CYDY CytoDyn Inc
11/16/2020 5:37:53 PM
Even 14-days post-293 enrollees, a (2)
CYDY CytoDyn Inc
11/13/2020 3:18:44 PM
Another view: Maraviroc, a small mo (5)
CYDY CytoDyn Inc
11/06/2020 9:46:16 PM
Repeating: information lies in even (5)
CYDY CytoDyn Inc
11/06/2020 9:42:21 PM
I hope I can help on the power fron (10)
CYDY CytoDyn Inc
10/29/2020 12:16:49 AM
Ohm - I've been trying to understan (4)
CYDY CytoDyn Inc
10/28/2020 6:14:15 PM
Only 6.5% of the placebo patients i (3)
CYDY CytoDyn Inc
10/28/2020 4:20:34 PM
Agree - it's clearly an "uneven pla (12)
CYDY CytoDyn Inc
10/26/2020 8:13:50 PM
Exactly. Information is measured in
CYDY CytoDyn Inc
10/21/2020 12:23:45 AM
So - the Meso GvHD CRL wasn't on hi (2)
CYDY CytoDyn Inc
10/21/2020 12:10:22 AM
Increasing mortality to 42 days is (4)
CYDY CytoDyn Inc
10/20/2020 10:06:17 PM
Rahman was just 13 months into runn
CYDY CytoDyn Inc
10/20/2020 12:39:58 PM
Let's not forget that OncoImmune pu
CYDY CytoDyn Inc
10/20/2020 10:22:09 AM
It's been a couple of hours - where (4)
CYDY CytoDyn Inc
10/18/2020 5:02:34 PM
Agree, sub-group analysis sucks - l
CYDY CytoDyn Inc
10/18/2020 11:50:42 AM
We will do a cohort (S alone, C alo (1)
CYDY CytoDyn Inc
10/16/2020 7:33:25 PM
Enrollment during interim analysis?
CYDY CytoDyn Inc
10/16/2020 7:24:08 PM
The 7-category ordinal scale: 1=dea (3)
CYDY CytoDyn Inc
10/16/2020 7:12:14 PM
Endpoint changes based solely on in (1)
CYDY CytoDyn Inc
10/16/2020 1:14:09 AM
By what process did OncoImmune deci
Go to page:
  • << First
  • < Previous
  • 4
  • 5
  • Next >

Recent Articles

  • HaemaLogiX Celebrates Recognition for Innovative CAR-T Advancements
  • Bioptimus Launches Scientific Advisory Board for AI in Biology
  • HaemaLogiX Triumphs with Award for Innovative CAR-T Pipeline
  • California's Electricity Bill Sparks Concern Over Consumer Protection
  • CICC Drives Innovation at the 10th Belt and Road Summit
  • YOFC Unveils Advanced Tech Solutions at Leading Optical Expo
  • CICC’s Involvement at Belt and Road Summit Highlights Growth
  • Housing Market Crisis: Examining Fannie Mae and Freddie Mac's Role
  • Cryptocurrency Market Update: Bitcoin Soars Amid Cooling Inflation
  • Alibaba's $3.2 Billion Bond Raise to Enhance Cloud and AI Growth
  • The Tragic Shooting of Charlie Kirk: National Outrage Ensues
  • Yondr Group's Strategic Focus on Major Data Center Markets
  • Lantheus Holdings Inc. Faces Class Action Suit: Investors Alert
  • China Telecom Global Showcases AI and Digital Innovation
  • LB Pharmaceuticals' Initial Public Offering Sets New Benchmark
  • SPX FLOW Expands Brisbane Facility for Enhanced Capabilities
  • LB Pharmaceuticals Sets Price for Initial Public Offering
  • Fosun International's Journey: Recognized for ESG Excellence and Innovation
  • Honoring Charlie Kirk: A Message of Compassion and Hope
  • Fosun International Shines in 2025 Admired Companies List
  • Unveiling the GFX ETERNA 55: A Game Changer in 8K Filmmaking
  • Wesbanco Reveals Details of Its New Preferred Stock Offering
  • Labs Investor Group Readies Two Major Funds for Impact
  • Sunset World Group Celebrates Independence with Festivities
  • Wheaton Precious Metals Backs Carcetti Capital’s Hemlo Mine Deal
  • Transforming Executive Risk Coverage with Innovative Solutions
  • Carcetti Capital's Strategic Acquisition to Propel Growth
  • Transformations of $1000 Investment in Amazon Over a Decade
  • Barrick Mining Corporation Completes Major Hemlo Gold Sale
  • Investors Rally Behind Lantheus Holdings Amid Lawsuit News
  • PayPal's Strategic Investment in Kite Boosts Digital Commerce Potential
  • Britannica Takes Legal Action Against Perplexity for Infringement
  • Silvercorp's 2025 Sustainability Report Showcases Progress
  • Barrick Mining's Strategic Sale of Hemlo Gold Mine Explained
  • AuguStar Life Insurance Completes Cash Tender Offer Process
  • Investment Growth: Transforming $1000 Into Over $8000 With EQIX
  • SK hynix Launches Game-Changing Mobile NAND Solution ZUFS 4.1
  • The Incredible Growth of Manhattan Associates Over Two Decades
  • High Point University Unveils State-of-the-Art Dental School
  • London's Emergence as a Leading Tech Hub in North America
  • Empowering Communities to Combat Child Trafficking Together
  • Opendoor Welcomes Kaz Nejatian as New CEO and Innovator
  • CAPREIT Achieves Major Milestone with International Plaza Sale
  • Transforming $100 Into Over $1000: Veeva Systems Success
  • Unlocking Flight with the MAVERICK: A Revolutionary Running Shoe
  • Teamsters Local 332 Demand Better Conditions at Rally
  • Transforming Steel Production: Metal Logic's Clean Solution
  • Q2 Metals Updates Exploration Insights on Cisco Lithium Target
  • Understanding MercadoLibre's Impressive Growth Over Five Years
  • Public Sentiment Declines for Trump amid Economic Concerns
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site